in caricamento ...

ST. JUDE Medical (STJ) – Insider all'opera

Scritto il 28 Aprile 2006 alle 15:19 da Danilo DT

St. Jude Medical, Inc. (St. Jude), together with its subsidiaries, develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management (CRM), cardiac surgery (CS), and cardiology and vascular access (C/VA) therapy areas. The Company’s principal CRM products are bradycardia pacemaker systems (pacemakers), tachycardia implantable cardioverter defibrillator systems and electrophysiology catheters. Its principal CS products are mechanical and tissue heart valves, valve-repair products, and epicardial ablation systems. C/VA products include vascular closure devices, angiography catheters, guidewires and hemostasis introducers. The Company sells its products in the United States, Europe, Japan, Canada, Latin America, Australia, New Zealand and the Asia-Pacific region. During the year ended December 31, 2004, St. Jude received Food and Drug Administration (FDA) approval for its line of products designed to treat heart failure.

Debt/Equity Ratio -> 0.06 (non ha debiti)

Risulta che nelle scorse sedute la società sia stata ben acquistata da alcuni managers operanti all’interno della stessa. Il segnale è senza dubbio positivo. Il titolo ha corretto molto ed è in fase di inversione.